FDA Inspection 1101385 — Loma Linda University Medical Center
The FDA completed an inspection of Loma Linda University Medical Center on August 14, 2019 in Loma Linda, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 14, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Loma Linda, CA (United States)